Inventor
YEUNG MING C
US26 patents
⚠️ This page may combine multiple inventors who share the name “YEUNG MING C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
9 patentsUS6455571B1Sep 24, 2002
Inhibitors of neuraminidases
ABBOTT LAB60 citations95
US7517876B2Apr 14, 2009
Anti-infective agents
ABBOTT LAB13 citations83
US7378414B2May 27, 2008
Anti-infective agents
ABBOTT LAB17 citations82
US6518305B1Feb 11, 2003
Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
ABBOTT LAB6 citations62
US6831096B2Dec 14, 2004
Inhibitors of neuraminidases
ABBOTT LAB3 citations61
US7834043B2Nov 16, 2010
HIV protease inhibiting compounds
ABBOTT LAB1 citations51
US7696226B2Apr 13, 2010
HIV protease inhibiting compounds
ABBOTT LAB1 citations51
US7538105B2May 26, 2009
Anti-infective agents
ABBOTT LAB0 citations50
US7902203B2Mar 8, 2011
Anti-infective agents
ABBOTT LAB0 citations39
ABBVIE OVERSEAS SARL
5 patentsUS10988454B2Apr 27, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL1 citations70
US10981890B2Apr 20, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations59
US10844041B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10844042B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10829473B2Nov 10, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
ABBVIE SARL
4 patentsUS10118916B2Nov 6, 2018
Modulators of cystic fibrosis transmembrane conductance regulator protein
ABBVIE SARL30 citations93
US9981910B2May 29, 2018
Substituted pyrrolidines and methods of use
ABBVIE SARL31 citations92
US10399940B2Sep 3, 2019
Substituted pyrrolidines and methods of use
ABBVIE SARL4 citations71
US10428017B2Oct 1, 2019
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE SARL1 citations61